Jerrold D. Dotson, CPA

Jerrold D. Dotson, CPA

Chief Financial OfficeratVistagen Therapeutics· In proxies 2022–2023

Pay in FY2023-39% from the year before · Vistagen Therapeutics stock -89.9% the same year

Jerrold D. Dotson, CPA was paid $434.4K in FY2023 (Mar), down 39%. Vistagen Therapeutics stock fell 89.9% that year.

Pay$100 in the stock at the end of FY21 → $6
Pay is from the Summary Compensation Table of each Vistagen Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vistagen TherapeuticsPublic company · 4 yr
    • Chief Financial Officer2022 – Present · 4 yrStock in role -100%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?